scispace - formally typeset
J

Joseph M. Pilewski

Researcher at University of Pittsburgh

Publications -  322
Citations -  17263

Joseph M. Pilewski is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Lung transplantation & Cystic fibrosis. The author has an hindex of 65, co-authored 285 publications receiving 15142 citations. Previous affiliations of Joseph M. Pilewski include Boston Children's Hospital & University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

Distribution of integrin cell adhesion receptors on normal bronchial epithelial cells and lung cancer cells in vitro and in vivo

TL;DR: This study defines the integrin repertoire of human bronchial epithelial cells and sets the stage for future investigations exploring how the regulation and signal transduction mechanisms of these receptors might affect important pulmonary processes such as bronchia cell differentiation, wound healing, and malignant transformation.
Journal ArticleDOI

Expression of integrin cell adhesion receptors during human airway epithelial repair in vivo

TL;DR: Injured epithelium was found to be significantly more susceptible to gene transfer with a recombinant adenovirus, suggesting that the increased integrin expression has implications for the acquisition of adenOVirus infections and for lung-directed gene therapy.
Journal ArticleDOI

Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin.

TL;DR: A case of h MPV pneumonia in a lung transplant recipient presenting with respiratory failure and sepsis syndrome is reported, and hMPV was diagnosed by polymerase chain reaction, and treated with intravenous ribavirin with a successful outcome.
Journal ArticleDOI

AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells.

TL;DR: The findings suggest that novel therapies to activate AMPK in the CF airway may be beneficial by blunting excessive sodium and ASL absorption and by reducing excessive airway inflammation, which are major contributors to CF lung disease.